A SOX2-engineered epigenetic silencer factor represses the glioblastoma genetic program and restrains tumor development
Authors:
- Valerio BenedettiVBValerio Benedetti
- Federica BanfiFBFederica Banfi
- Mattia ZaghiMZMattia Zaghi
- Raquel Moll-DiazRMRaquel Moll-Diaz
- Luca MassiminoLMLuca Massimino
- Laura ArgelichLALaura Argelich
- Edoardo BelliniEBEdoardo Bellini
- Simone BidoSBSimone Bido
- Sharon MuggeoSMSharon Muggeo
- Gabriele OrdazzoGOGabriele Ordazzo
- Giuseppina MastrototaroGMGiuseppina Mastrototaro
Open Access
- 5 August 2022
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (31) , eabn3986
Abstract
Current therapies remain unsatisfactory in preventing the recurrence of glioblastoma multiforme (GBM), which leads to poor patient survival. By rational engineering of the transcription factor SOX2, a key promoter of GBM malignancy, together with the Kruppel-associated box and DNA methyltransferase3A/L catalytic domains, we generated a synthetic repressor named SOX2 epigenetic silencer (SES), which induces the transcriptional silencing of its original targets. By doing so, SES kills both glioma cell lines and patient-derived cancer stem cells in vitro and in vivo. SES expression, through local viral delivery in mouse xenografts, induces strong regression of human tumors and survival rescue. Conversely, SES is not harmful to neurons and glia, also thanks to a minimal promoter that restricts its expression in mitotically active cells, rarely present in the brain parenchyma. Collectively, SES produces a significant silencing of a large fraction of the SOX2 transcriptional network, achieving high levels of efficacy in repressing aggressive brain tumors.Keywords
This publication has 62 references indexed in Scilit:
- TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusionsGenome Biology, 2013
- Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancerNature Genetics, 2012
- A restricted cell population propagates glioblastoma growth after chemotherapyNature, 2012
- Fast gapped-read alignment with Bowtie 2Nature Methods, 2012
- Evaluation of a Droplet Digital Polymerase Chain Reaction Format for DNA Copy Number QuantificationAnalytical Chemistry, 2011
- I-TASSER: a unified platform for automated protein structure and function predictionNature Protocols, 2010
- Use of the Ki67 promoter to label cell cycle entry in living cellsCytometry Part A, 2010
- Direct conversion of fibroblasts to functional neurons by defined factorsNature, 2010
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005